Generation Lab provides the SystemAge™ Test, an epigenetic analysis that measures biological age across 460 biomarkers and 19 organ systems. This service delivers personalized action plans designed to help users slow the aging process and detect potential health risks before symptoms appear. The company facilitates access to affiliated longevity professionals for consultation and ongoing health optimization.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals lack accessible methods to quantify aging rates across different organ systems, hindering proactive health management. Traditional genetic tests do not provide insights into the real-time aging status of specific organs or the effectiveness of interventions. This makes it difficult to personalize and optimize strategies for longevity and disease prevention.
Solution
Generation Lab offers the SystemAge Test, an at-home cheek swab test that measures the biological age of 19 organs and systems. Using DNA methylation analysis, the test identifies biomarkers associated with aging and disease risk, providing a comprehensive view of an individual's aging trajectory. The SystemAge Test assesses the rate of aging in each organ, revealing whether aging is accelerating or decelerating. Results are used to create personalized action plans, which include customized lifestyle strategies and treatments designed to target areas needing the most support. Repeat testing enables users to monitor the impact of interventions and adjust their approach over time, facilitating a data-driven approach to longevity.
Target Audience
The primary audience includes individuals interested in proactive health management, longevity, and personalized medicine, as well as healthcare professionals seeking advanced diagnostic tools for assessing aging and disease risk.
Features
- Epigenetic analysis of DNA methylation patterns to determine biological age
- Assessment of aging rates across 19 distinct organs and systems
- Personalized action plans with tailored lifestyle and treatment recommendations
- Quarterly or bi-monthly testing options for continuous monitoring
- Clinician consultations to review results and action plans
- Online or in-person review of detailed lab reports
- Monitoring of intervention effectiveness through repeat testing